GCM
NVAX icon

Graham Capital Management’s Novavax NVAX Stock Holding History

Graham Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17M Sell
2,086,600
-444,000
-18% -$4.02M 0.41% 47
2025
Q4 		$17M Sell
2,530,600
-19,300
-0.8% -$145K 0.41% 46
2025
Q3 		$22.1M Buy
2,549,900
+100,000
+4% +$778K 0.35% 37
2025
Q2 		$6.29M Buy
2,449,900
+2,005,900
+452% +$13.3M 0.1% 110
2025
Q1 		$2.85M Hold
444,000
– – 0.05% 233
2024
Q4 		$3.57M Hold
444,000
– – 0.05% 176
2024
Q3 		$5.61M Hold
444,000
– – 0.1% 114
2024
Q2 		$5.62M Sell
444,000
-863,200
-66% -$8.68M 0.12% 100
2024
Q1 		$6.25M Buy
1,307,200
+606,200
+86% +$2.81M 0.12% 103
2023
Q4 		$3.36M Buy
701,000
+232,200
+50% +$1.42M 0.07% 145
2023
Q3 		$3.39M Buy
468,800
+60,100
+15% +$480K 0.08% 140
2023
Q2 		$3.04M Sell
408,700
-296,200
-42% -$2.33M 0.09% 158
2023
Q1 		$4.88M Buy
704,900
+624,900
+781% +$5.75M 0.15% 88
2022
Q4 		$822K Buy
+80,000
New +$1.41M 0.03% 614
2022
Q1 		– Sell
-211,300
Closed -$30.2M – 986
2021
Q4 		$30.2M Buy
211,300
+161,300
+323% +$27.7M 1.29% 18
2021
Q3 		$10.4M Buy
+50,000
New +$11M 0.53% 37
2020
Q1 		– Sell
-250,000
Closed -$995K – 83
2019
Q4 		$995K Hold
250,000
– – 0.04% 76
2019
Q3 		$1.25M Buy
+250,000
New +$1.37M 0.04% 85

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Graham Capital Management's NVAX Position: Q1 2026 in Review

Graham Capital Management reduced its Novavax (NVAX) stake by 52% in Q1 2026, selling an estimated $193K and leaving 19,336 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Graham Capital Management first reported a position in NVAX in Q4 2020 and has held it in 9 quarters since. The position peaked at $4.19M in Q4 2020. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Graham Capital Management held 19,336 shares of Novavax worth $157K as of Q1 2026.
  • Graham Capital Management sold 21,284 Novavax shares in Q1 2026, an estimated $193K.
  • Novavax made up ﹤0.01% of Graham Capital Management's portfolio in Q1 2026, its #993 holding.
  • Graham Capital Management first reported a position in Novavax in Q4 2020 and has held it in 9 quarters since.
  • Graham Capital Management's Novavax position peaked at $4.19M in Q4 2020.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Graham Capital Management's 13F filing for Q1 2026, filed 15 May 2026.